Evidence map›Paper›PMID 41020681›Full record

ReviewCancer medicine2025

Research Advances of the Effects of Food and Medicine Homology Substances on Gastric Cancer.

Zhengyang Hao, Xiangjun Chen, Wenqian Tang, Ruipeng Wu, Bei Xue, Jingzhe Chen, Yidan Zhang, Shaokang Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhengyang HaoClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.ORCID https://orcid.org/0009-0007-1913-7989
Xiangjun ChenClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.
Wenqian TangKey Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, China.
Ruipeng WuClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.
Bei XueClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.
Jingzhe ChenClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.
Yidan ZhangClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.
Shaokang WangClinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, and School of Medicine, Xizang Minzu University, Xianyang, China.

Funding

Natural Science Foundation of Xizang Autonomous Region XZ202401ZR0130Science and Technology Projects of Xizang Autonomous Region, China XZ202501JD0007Special Project of the Central Government in Guidance of Local Science and Technology Development of the Xizang Autonomous Region XZ202401YD0010Xizang University for Nationalities Intramural Research Project 22MDY06
6 · The paper itself

Abstract

backgroundGastric cancer (GC), a common malignant tumor, poses a significant threat to human health. Conventional radiotherapy and chemotherapy regimens come with significant drawbacks, including high toxicity, adverse side effects, inadequate targeting ability, and the potential for developing drug resistance, which ultimately diminishes patients' overall well-being.

methodsFood and medicine homology substances exhibit favorable pharmacological activity and minimal toxic side effects. They comprise a range of components that are beneficial to the human body, including high-quality proteins, vitamins, minerals, and other biologically active components such as polysaccharides, flavonoids, saponins, and alkaloids. In recent years, they have attracted considerable attention in the field of GC prevention and treatment. A comprehensive review of extant literature, alongside a rigorous analysis of contemporary nutrition and traditional Chinese medicine, forms the foundation of this study.

resultsIts systematic approach encompasses the examination of the effects and mechanisms of food and medicine homology substances and their active ingredients on the prophylaxis and therapy of GC.

conclusionsThe study's findings expand the cognitive boundaries of GC prevention and improvement and offer novel insights and directions for the development of clinical anticancer therapeutic drugs.

Indexed as

Stomach NeoplasmsAnimalsHumansMedicine, Chinese Traditionalactive ingredientsfood and medicine homology substancesgastric cancermechanisms of action

Identifiers

PMID41020681
PMCPMC12477795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.